Everolimus
mTOR inhibitor for transplant rejection and several cancers.
- Starts working
- Weeks
- Half-life
- About 30 hours
- In use since
- —
- Pregnancy
- Usually avoided
Overview
Everolimus is used at low doses to prevent organ rejection (Certican/Zortress) and at higher doses for breast, kidney, neuroendocrine tumours and tuberous sclerosis. The two uses use different products and doses.
Conditions it's used for
How it works
Stops immune or tumour cell growth signals.
Everolimus belongs to the mTOR inhibitors. How mTOR inhibitors work: stop immune and cancer cells responding to growth signals.
Uses
- Kidney or liver transplant rejection prevention
- Hormone-positive breast cancer (with exemestane)
- Kidney cancer
- Neuroendocrine tumours
- Tuberous sclerosis complex
Available as: tablet, dispersible tablet.
Typical dose
- Adults
- Oncology: 10 mg once a day. Transplant: 0.75–1 mg twice a day adjusted to levels.
- Good to know
- Do not swap the oncology and transplant products.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Mouth ulcers
- Rash
- Tiredness
- Raised cholesterol and blood sugar
- Swollen ankles
Serious — get medical help
Uncommon, but need prompt attention
- Lung inflammation
- Serious infections
- Kidney impairment
- Poor wound healing
Warnings
- Dose depends on the indication; do not swap products
- Mouth rinse with steroid solution prevents ulcers
Who should avoid it
- Pregnancy
- Severe liver impairment
Interactions
- Ketoconazole, clarithromycin, ritonavir — much higher levels
- Rifampicin, St John's wort — lower levels
- Ciclosporin — raises everolimus levels
- ACE inhibitors — higher angioedema risk
- Live vaccines — avoid
Other medicines in the atlas that need care with Everolimus, grouped by the reason:
Reduced effectModerateWith Carbamazepine, Efavirenz, Enzalutamide, Griseofulvin, Modafinil and 5 more
Enzyme induction lowers levels of this medicine, which may stop it working.
What's usually done: Monitor effect; dose changes or alternatives may be needed. The effect lasts weeks after stopping the inducer.
Raised drug levelsModerateWith Clarithromycin, Darunavir, Erythromycin, Itraconazole, Lopinavir-ritonavir and 2 more
Blocking CYP3A4 increases levels of this medicine, so side effects become more likely.
What's usually done: A dose reduction, alternative or extra monitoring may be needed.
Using it safely
- Alcohol
- Best to limit. Alcohol adds to mouth sores and liver strain.
- Food and drink
- Take consistently with or without food; avoid grapefruit.
- If you miss a dose
- Take within 6 hours; otherwise skip.
- Stopping it
- Only on advice of your specialist.
- Driving
- Tiredness may affect driving.
- Tests and checks
- Everolimus levels (transplant); Lipids; Glucose; Kidney function; Mouth ulcers
- If too much is taken
- Seek advice.
- Storage
- Room temperature.
- Legal status
- United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HAustralia: Prescription only (Schedule 4)
Pregnancy and breastfeeding
Pregnancy
Usually avoided
Avoid; effective contraception advised.
Breastfeeding
Usually avoided
Avoid.
Special groups
- Kidney disease
- Dose by levels or indication.
- Liver disease
- Reduce the dose in impairment.
- Older adults
- Use caution.
Brand names
- United States
- Afinitor, Zortress
- United Kingdom
- Afinitor, Certican
- India
- Afinitor, Certican, Everolimus (generic)
- Australia
- Afinitor, Certican
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Do I need a prescription for Everolimus?
Yes — Everolimus is prescription-only in most countries.
Can I take Everolimus during pregnancy?
Usually avoided. Avoid; effective contraception advised. Always check with a doctor or midwife.
How quickly does Everolimus work?
Weeks.
Related medicines
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — L04AA18
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.